Identification |
Name: | 2,6-Piperidinedione,4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]- |
Synonyms: | 2,6-Piperidinedione,4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, [1S-[1a(S*),3a,5b]]-; Glutarimide, 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-(7CI,8CI); Naramycin A (6CI);3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide; Acti-Aid;Acti-dione; Acti-dione BR; Acti-dione PM; Acti-dione TGF; Actidion;Cicloheximide; Cycloheximide; LDN 97549; NM-MCD 80; NSC 185; Naramycin;Naramycin Microcapsule D 80; Naramycin NM-MCU 80; TZA; U 4527; b-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide |
CAS: | 21059-09-6 |
Molecular Formula: | C15H23 N O4 |
Molecular Weight: | 0 |
InChI: | InChI=1/C15H23NO4/c1-8-5-9(2)14(19)12(6-8)11-7-13(18)16-15(20)10(11)3-4-17/h8-12,17H,3-7H2,1-2H3,(H,16,18,20) |
Molecular Structure: |
|
Properties |
Flash Point: | 249.1°C |
Boiling Point: | 488.3°Cat760mmHg |
Density: | 1.138g/cm3 |
Refractive index: | 1.5 |
Flash Point: | 249.1°C |
Safety Data |
|
|